COSMOS Pharmaceutical Corporation (TYO:3349)
Japan flag Japan · Delayed Price · Currency is JPY
6,383.00
-497.00 (-7.22%)
Jul 31, 2026, 3:30 PM JST

COSMOS Pharmaceutical Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, COSMOS Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥7,571. The average 1-year stock price forecast is 18.61% higher than the current stock price, while the lowest is ¥6,500 (+1.83%) and the highest is ¥9,600 (+50.40%).

Price Target: ¥7,571 (+18.61%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥6,500¥7,571¥7,500¥9,600
Change+1.83%+18.61%+17.50%+50.40%

Analyst Ratings

The average analyst rating for COSMOS Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy444444
Buy222221
Hold444445
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Downgrades
¥9,300¥7,300
HoldDowngrades¥9,300¥7,300+14.37%Jul 10, 2026

Financial Forecast

Revenue This Year
1.19T
from 1.10T
Increased by 8.15%
Revenue Next Year
1.27T
from 1.19T
Increased by 6.93%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMay 31, 2022May 31, 2023May 31, 2024May 31, 2025May 31, 2026May 31, 2027
Revenue
755.41B827.70B964.99B1.01T1.10T1.19T
Revenue Growth
3.99%9.57%16.59%4.81%8.72%8.15%
Gross Profit
151.45B168.72B188.31B213.28B229.68B249.50B
Gross Margin
20.05%20.38%19.51%21.09%20.89%20.98%
Operating Income
29.80B30.13B31.50B40.40B41.91B44.02B
Net Income
23.16B23.80B24.45B30.98B32.05B32.27B
Dividend / Share
40.0050.0060.0070.0082.0084.25
Dividend Growth
-25.00%20.00%16.67%17.14%2.74%
Free Cash Flow
-15.32B5.04B-7.99B-6.53B-18.19B3.70B
No. Analysts
-----8
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High1.2T
Avg1.2T
Low1.2T

Revenue Growth

Revenue Growth202720282029
High
8.8%
Avg
8.2%
Low
7.8%

EPS Forecast

EPS202720282029
High-
Avg-
Low-

EPS Growth

EPS Growth20282029
High-
Avg-
Low-